News
Self-Care is Not Selfish!
Self-care has become a buzz word in recent years, and the self-care plan templates that are being used are not...
Phase 3 Trial Finds that a Structured Exercise Program Significantly Improves Survival and Reduces Recurrence in Colorectal Cancer Patients
A randomized phase 3 trial (CHALLENGE, CO.21) conducted by the Canadian Cancer Trials Group found that a 3-year structured exercise...
New Treatment Combination Lowers Risk of Death by Half for Patients with BRAFV600E-Mutated Metastatic Colorectal Cancer
New results from the Phase 3 BREAKWATER clinical trial show that a combination treatment including BRAFTOVI® (encorafenib), cetuximab, and chemotherapy...
Aspirin use following adjuvant therapy does not improve disease outcomes in colorectal cancer patients
A large phase 3 trial (ASCOLT) found that daily aspirin use for 3 years after standard adjuvant therapy (treatment given...
Early-Life Exposure to Bacterial Toxin Linked to Increased Risk of Early-Onset Colorectal Cancer
A recent study published in Nature by Díaz-Gay et al. has linked early-life exposure to a bacterial toxin called colibactin,...
Improving Safety in Polyp Removal: The Closure Trial
Colorectal cancer often starts as a small polyp that slowly grows until it becomes cancerous. Research indicates that once a...
Get social
Self-Care is Not Selfish!
Self-care has become a buzz word in recent years, and the self-care plan templates that are being used are not...
Phase 3 Trial Finds that a Structured Exercise Program Significantly Improves Survival and Reduces Recurrence in Colorectal Cancer Patients
A randomized phase 3 trial (CHALLENGE, CO.21) conducted by the Canadian Cancer Trials Group found that a 3-year structured exercise...
New Treatment Combination Lowers Risk of Death by Half for Patients with BRAFV600E-Mutated Metastatic Colorectal Cancer
New results from the Phase 3 BREAKWATER clinical trial show that a combination treatment including BRAFTOVI® (encorafenib), cetuximab, and chemotherapy...
Aspirin use following adjuvant therapy does not improve disease outcomes in colorectal cancer patients
A large phase 3 trial (ASCOLT) found that daily aspirin use for 3 years after standard adjuvant therapy (treatment given...
Early-Life Exposure to Bacterial Toxin Linked to Increased Risk of Early-Onset Colorectal Cancer
A recent study published in Nature by Díaz-Gay et al. has linked early-life exposure to a bacterial toxin called colibactin,...
Improving Safety in Polyp Removal: The Closure Trial
Colorectal cancer often starts as a small polyp that slowly grows until it becomes cancerous. Research indicates that once a...
